Syndax Pharmaceuticals Inc (SNDX) › Shares OutstandingSyndax Pharmaceuticals Inc (SNDX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 85.4K2016: 18.22M2017: 24.39M2018: 24.84M2019: 27.14M2020: 47.88M2021: 54.98M2022: 68.11M2023: 84.83M2024: 85.69M2025: 87.41M87.41M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202587.41M+2.0%202485.69M+1.0%202384.83M+24.5%202268.11M+23.9%202154.98M+14.8%202047.88M+76.4%201927.14M+9.3%201824.84M+1.8%201724.39M+33.9%201618.22M+21219.3%201585.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share